Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. - Wikidata - wikimedia - TriplyDB

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

http://www.wikidata.org/entity/Q34059673

about

Aldehyde dehydrogenase 1A1 in stem cells and cancer Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia Stem cells, colorectal cancer and cancer stem cell markers correlations CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care Gastrointestinal stem cell up-to-date Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer Comparison of putative circulating cancer stem cell detection between the hepatic portal system and peripheral blood in colorectal cancer patients Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.Prognostic role of CD133 expression in colorectal cancer: a meta-analysis Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.Preoperative chemoradiotherapy in rectal cancer induces changes in the expression of nuclear β-catenin: prognostic significance.Lung fibroblasts share mesenchymal stem cell features which are altered in chronic obstructive pulmonary disease via the overactivation of the Hedgehog signaling pathway Early diagnosis, treatment and prognosis of epilepsy with continuous spikes and waves during slow sleep Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis.Cell polarity, epithelial-mesenchymal transition, and cell-fate decision gene expression in ductal carcinoma in situ.A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance Polycomb repressive complex 2 impedes intestinal cell terminal differentiation.Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.Colorectal cancer biomarkers and the potential role of cancer stem cells.Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma.CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis.Loss of TINCR expression promotes proliferation, metastasis through activating EpCAM cleavage in colorectal cancer.Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.The association between CD166 detection rate and clinicopathologic parameters of patients with colorectal cancer.Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.Detection of Cancer Stem Cells in Colorectal Cancer: Histopathological and Immunohistochemical Study Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses.Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.

P2860

Q26771185-E9A3EF3A-5639-4AFB-86E3-414DD45FD130 Q26774811-DB56BD1B-F2DF-42D6-A017-16FCA90C04C2 Q26799954-12B3DA5F-5919-4ABF-81E5-750320475AE3 Q26823217-BF197E61-BFFD-4875-8F73-B502D8F1FC74 Q26827628-D97E9A1A-8A47-4AE1-A86D-4BFD87B09312 Q27004062-0F6613FB-1B98-4449-974A-33DDFCC8F8AA Q27024651-AB721766-1197-4135-8C66-9AE421C4060A Q27852992-814EEF1C-E9D1-43A3-AC45-F3CDD4F59F02 Q28066460-B26C3781-832C-4034-AE69-7D4BD972E8CD Q28088455-CC8BD50A-2327-46C4-8C94-1E99AA05A8EB Q33750119-F8C87FFB-7F3F-4A12-A7D8-ED8FA759B1E1 Q33898776-2A2C5804-8A1F-4373-B7E2-F1C15BA9F982 Q33943803-DB4F3495-249E-4563-A411-9A72588330BE Q34441291-7DC94C5E-6DD2-4285-B49E-D018273F366E Q34478477-E7AAAB9A-F01F-406E-BA15-4FD7BC908AD2 Q34502600-71994DD0-6EA1-4CE0-B16A-8301D51A548A Q34936453-DC26D78C-BAA4-4E55-8362-A07A457727F0 Q35120863-64374684-5E11-49E5-8ECD-C23D15E6D18B Q35224807-7AC5631F-C29A-40D4-837F-C09230FF7B57 Q35643873-616D3A5A-AEA4-4159-B9FD-807D125C4853 Q35833372-26AAFA1C-FEF0-4108-8D8F-655068E6A02E Q35909091-5CB96E2A-CD4F-40E9-99E9-6A075E3ED5CF Q36005675-281510E3-C5B8-414B-B4C5-63AA5F62A31C Q36303850-393618B5-B74D-4B62-9FF4-67B3A27D051C Q36358764-17A2DBCF-DE93-472B-B230-9CC3A67A5839 Q36449835-1EEF9698-0562-4FC1-82B3-E1D0BB6624AC Q36451004-17FC8AC8-E8BA-4121-86CE-44551F4BACE9 Q36642164-20C82F85-ABA1-45B1-9A4A-95DD7A999E48 Q36646553-C35064FA-5A60-47C5-8A36-33BAEA030E1C Q36957616-80D47441-8111-41F0-970D-D437A5EF5039 Q37046355-F894BEBE-44FB-4513-BC22-A9E7D08FC805 Q37118119-4743EEB9-7AB6-4488-BFEB-F3D78739D888 Q37225623-C3B25756-625D-4FCB-A6BB-8EB71206AD8D Q37269916-DCFA7C75-EF5E-409E-B6E5-4E8D6809F8FD Q37345963-EA506D50-8E4A-42A3-BBBE-6D45CC41AB0A Q37348476-BA2DAEE9-EF20-473C-B041-76A31572B1EE Q37507482-CC6C6E22-E24F-4FA3-B8EC-7BB603184AD1 Q37523513-B9257293-3A49-45B4-8FB1-33569DAB3091 Q37564476-8D1898AB-1A63-4998-B508-2C7C139BACB5 Q37583804-C8E2C4AB-4704-4772-A3AB-96203C5AE084

P2860

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

http://www.wikidata.org/entity/Q34059673

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Prognostic impact of the expre ...... nd ALDH1 in colorectal cancer.

@ast

Prognostic impact of the expre ...... nd ALDH1 in colorectal cancer.

@en

Prognostic impact of the expre ...... nd ALDH1 in colorectal cancer.

@nl

type

label

Prognostic impact of the expre ...... nd ALDH1 in colorectal cancer.

@ast

Prognostic impact of the expre ...... nd ALDH1 in colorectal cancer.

@en

Prognostic impact of the expre ...... nd ALDH1 in colorectal cancer.

@nl

prefLabel

Prognostic impact of the expre ...... nd ALDH1 in colorectal cancer.

@ast

Prognostic impact of the expre ...... nd ALDH1 in colorectal cancer.

@en

Prognostic impact of the expre ...... nd ALDH1 in colorectal cancer.

@nl

P1433

Q34059673-EEA71717-3FDB-472C-AAAA-8129843A0D3D

P1476

Q34059673-91134FF2-DF3B-47C9-BEF3-4F380333E136

P2093

Q34059673-0ED5C556-F62C-40A7-A487-6AC524881E64

Q34059673-2EB0E8E5-D384-42A5-8A4E-6E88A164E855

Q34059673-3059F07B-E556-458C-BBA6-D98F1ECB0F60

Q34059673-5A0E4E7A-8FDC-4D21-A38E-D07EAF0B22FA

Q34059673-86C45D3A-BB79-40F6-8DD9-80BE4EC649D8

Q34059673-8F6DEB0B-EAB1-45A7-8F6B-B2A7E8546267

Q34059673-BB70146B-86E8-49DD-8CD4-149F757DDD80

Q34059673-EAB5D4CE-0AB0-4555-92D1-984D6AA3A253

Q34059673-F2887AE8-1277-4328-8454-0C2CEF6704D4

P2860

Q34059673-06778507-D830-42FB-A732-FF18A6125558

Q34059673-0B3EE193-66D4-47A3-8C9B-D2FD2FAA0F81

Q34059673-13A39175-4791-406E-BD1E-24C374661D48

Q34059673-2CFB09BA-98D4-4AEB-8392-CC3E89587CE9

Q34059673-308E08F0-6072-4AB0-8B37-B34B1483A25D

Q34059673-34216E5C-94D3-4F43-B00C-94566C0935CA

Q34059673-3C3F087C-7274-4C44-908B-F46E640C850A

Q34059673-4478672A-9D23-410A-A9DD-7D53DC973B3C

Q34059673-44B4D111-B0E3-4207-B618-B2591F67B144

Q34059673-4758BEA2-D582-4B15-9A2D-032122788579

P2888

Q34059673-41DBFC25-020B-4751-82FD-EF860511B1FF

P304

Q34059673-BA26FFE3-DDD1-4F4E-B40B-4AD23D85EF0F

P31

Q34059673-2897694F-0F42-423C-8C31-BE8ABC46AE0B

P356

Q34059673-27478376-60FE-457E-AF1A-F4F0A72FA183

P407

Q34059673-A2904B01-9E05-4B70-BD8D-5E6283E608B7

P433

Q34059673-5B88E686-4222-411C-B190-5FAE4ED65503

P478

Q34059673-0AC3FBF9-C8EC-4677-A01B-DC83735BD37F

P50

Q34059673-1B745121-BDE4-4C5D-A1BF-E257CF0AD2FF

P577

Q34059673-4E4A0F15-0F98-4F94-A4A9-557534E6B119

P5875

Q34059673-14F9DC81-362E-4BB9-822D-E5E337D38905

P6179

Q34059673-07B50E8D-1234-49F0-B143-CD688128CCAE

P698

Q34059673-5ADE88C6-20AE-414E-961D-0221360FAF47

P921

Q34059673-8DB3F9CF-E2F3-4ABD-A33B-58BD04F49AE0

P932

Q34059673-C25FB75D-14E7-4CFC-BBCB-CF901DFAC34B

P356

P1433

British Journal of Cancer

P1476

Prognostic impact of the expre ...... and ALDH1 in colorectal cancer

@en

P2093

A Lugli

http://www.w3.org/2001/XMLSchema#string

G Iezzi

http://www.w3.org/2001/XMLSchema#string

G Spagnoli

http://www.w3.org/2001/XMLSchema#string

I Hostettler

http://www.w3.org/2001/XMLSchema#string

I Zlobec

http://www.w3.org/2001/XMLSchema#string

L Terracciano

http://www.w3.org/2001/XMLSchema#string

M G Muraro

http://www.w3.org/2001/XMLSchema#string

V Carafa

http://www.w3.org/2001/XMLSchema#string

V Mele

http://www.w3.org/2001/XMLSchema#string

P2860

Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

Phenotypic characterization of human colorectal cancer stem cells

Identification and expansion of human colon-cancer-initiating cells

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Stem cells, cancer, and cancer stem cells

ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

P2888

P304

382-390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605762

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45097628

http://www.w3.org/2001/XMLSchema#string

P6179

1029337328

http://www.w3.org/2001/XMLSchema#string

P698

20606680

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2920016

http://www.w3.org/2001/XMLSchema#string